UB Paderborn / Katalog / Suche / in CDI

Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individuals

Metabolomics, 2015-02, Vol.11 (1), p.122-133

2015

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor‐induced colitis

Alimentary pharmacology & therapeutics, 2022-11, Vol.56 (9), p.1370-1382

2022

Link zum Volltext

Verfügbarkeit prüfen

Metabonomics in Gastroenterology and Hepatology

International journal of molecular sciences, 2019-07, Vol.20 (15), p.3638

2019

Link zum Volltext

Verfügbarkeit prüfen

Lipidomic Trajectories Characterize Delayed Mucosal Wound Healing in Quiescent Ulcerative Colitis and Identify Potential Novel Therapeutic Targets

International journal of biological sciences, 2022-01, Vol.18 (5), p.1813-1828

2022

Link zum Volltext

Verfügbarkeit prüfen

Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease

BMC medicine, 2017-10, Vol.15 (1), p.184-184, Article 184

2017

Link zum Volltext

Verfügbarkeit prüfen

IL-33 is upregulated in colonocytes of ulcerative colitis

Immunology letters, 2010-01, Vol.128 (1), p.80-85

2010

Link zum Volltext

Verfügbarkeit prüfen

Rectal Cancer Risk After Colectomy in Patients With Inflammatory Bowel Disease—A Population-Based Danish Cohort Study 1978–2018

Gastro hep advances, 2023, Vol.2 (6), p.853-859

2023

Link zum Volltext

Verfügbarkeit prüfen

COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis

Journal for immunotherapy of cancer, 2022-09, Vol.10 (9), p.e005111

2022

Link zum Volltext

Verfügbarkeit prüfen

CARD15 status and familial predisposition for crohn's disease and colonic gene expression

Digestive diseases and sciences, 2007-08, Vol.52 (8), p.1783-1789

2007

Link zum Volltext

Verfügbarkeit prüfen

Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report

BMJ open gastroenterology, 2022-12, Vol.9 (1), p.e000989

2022

Link zum Volltext

Verfügbarkeit prüfen

Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial

EClinicalMedicine, 2022-03, Vol.45, p.101332-101332, Article 101332

2022

Link zum Volltext

Verfügbarkeit prüfen

Influence of smoking on colonic gene expression profile in Crohn's disease

PloS one, 2009-07, Vol.4 (7), p.e6210-e6210

2009

Link zum Volltext

Verfügbarkeit prüfen

miR-20b, miR-98, miR-125b-1, and let-7e as new potential diagnostic biomarkers in ulcerative colitis

World journal of gastroenterology : WJG, 2013, Vol.19 (27), p.4289

Coskun, Mehmet

2013

Link zum Volltext

Verfügbarkeit prüfen

Non-infectious HIV-associated colitis as a differential diagnosis to ulcerative colitis

Scandinavian journal of gastroenterology, 2016-08, Vol.51 (8), p.1017-1018

2016

Link zum Volltext

Verfügbarkeit prüfen

Early Intestinal Ultrasound Predicts Intravenous Corticosteroid Response in Hospitalised Patients With Severe Ulcerative Colitis

Journal of Crohn's and colitis, 2022-11, Vol.16 (11), p.1725-1734

2022

Link zum Volltext

Verfügbarkeit prüfen

Alpha-1 antitrypsin and granulocyte colony-stimulating factor as serum biomarkers of disease severity in ulcerative colitis

Inflammatory bowel diseases, 2015-05, Vol.21 (5), p.1077-1088

2015

Link zum Volltext

Verfügbarkeit prüfen

Recent Advances Using Immunomodulators for Inflammatory Bowel Disease

Journal of clinical pharmacology, 2013-06, Vol.53 (6), p.575-588

2013

Link zum Volltext

Verfügbarkeit prüfen

Genome‐wide gene expression analysis of mucosal colonic biopsies and isolated colonocytes suggests a continuous inflammatory state in the lamina propria of patients with quiescent ulcerative colitis

Inflammatory bowel diseases, 2010-06, Vol.16 (6), p.999-1007

2010

Link zum Volltext

Verfügbarkeit prüfen

Integration of transcriptomics and metabonomics: improving diagnostics, biomarker identification and phenotyping in ulcerative colitis

Metabolomics, 2014-04, Vol.10 (2), p.280-290

2014

Link zum Volltext

Verfügbarkeit prüfen

Metabonomics: methods and protocols: preface

Methods in molecular biology (Clifton, N.J.), 2015, Vol.1277, p.v

Bjerrum, Jacob Tveiten

2015

Link zum Volltext

Verfügbarkeit prüfen

Acute Experimental Barrier Injury Triggers Ulcerative Colitis–Specific Innate Hyperresponsiveness and Ulcerative Colitis–Type Microbiome Changes in Humans

Cellular and molecular gastroenterology and hepatology, 2021-01, Vol.12 (4), p.1281-1296

2021

Link zum Volltext

Verfügbarkeit prüfen

Integrative Transcriptomic and Metabonomic Molecular Profiling of Colonic Mucosal Biopsies Indicates a Unique Molecular Phenotype for Ulcerative Colitis

Journal of proteome research, 2015-01, Vol.14 (1), p.479-490

2015

Link zum Volltext

Verfügbarkeit prüfen

miR-20b, miR-98, miR-125b-1, and let-7e as new potential diagnostic biomarkers in ulcerative colitis

World journal of gastroenterology : WJG, 2013-07, Vol.19 (27), p.4289-4299

2013

Link zum Volltext

Verfügbarkeit prüfen

Acute Experimental Barrier Injury Triggers Ulcerative Colitis–Specific Innate Hyperresponsiveness and Ulcerative Colitis–Type Microbiome Changes in HumansSummary

Cellular and molecular gastroenterology and hepatology, 2021-01, Vol.12 (4), p.1281-1296

2021

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individuals

Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor‐induced colitis

Metabonomics in Gastroenterology and Hepatology

Lipidomic Trajectories Characterize Delayed Mucosal Wound Healing in Quiescent Ulcerative Colitis and Identify Potential Novel Therapeutic Targets

Characterization of the enhancer and promoter landscape of inflammatory bowel disease from human colon biopsies

Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease

IL-33 is upregulated in colonocytes of ulcerative colitis

Rectal Cancer Risk After Colectomy in Patients With Inflammatory Bowel Disease—A Population-Based Danish Cohort Study 1978–2018

COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis

CARD15 status and familial predisposition for crohn's disease and colonic gene expression

Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report

Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial

Influence of smoking on colonic gene expression profile in Crohn's disease

miR-20b, miR-98, miR-125b-1, and let-7e as new potential diagnostic biomarkers in ulcerative colitis

Non-infectious HIV-associated colitis as a differential diagnosis to ulcerative colitis

Early Intestinal Ultrasound Predicts Intravenous Corticosteroid Response in Hospitalised Patients With Severe Ulcerative Colitis

Alpha-1 antitrypsin and granulocyte colony-stimulating factor as serum biomarkers of disease severity in ulcerative colitis

Recent Advances Using Immunomodulators for Inflammatory Bowel Disease

Genome‐wide gene expression analysis of mucosal colonic biopsies and isolated colonocytes suggests a continuous inflammatory state in the lamina propria of patients with quiescent ulcerative colitis

Integration of transcriptomics and metabonomics: improving diagnostics, biomarker identification and phenotyping in ulcerative colitis

Metabonomics: methods and protocols: preface

Acute Experimental Barrier Injury Triggers Ulcerative Colitis–Specific Innate Hyperresponsiveness and Ulcerative Colitis–Type Microbiome Changes in Humans

Integrative Transcriptomic and Metabonomic Molecular Profiling of Colonic Mucosal Biopsies Indicates a Unique Molecular Phenotype for Ulcerative Colitis

miR-20b, miR-98, miR-125b-1, and let-7e as new potential diagnostic biomarkers in ulcerative colitis

Acute Experimental Barrier Injury Triggers Ulcerative Colitis–Specific Innate Hyperresponsiveness and Ulcerative Colitis–Type Microbiome Changes in HumansSummary

Suchergebnisse filtern